Filter
287
Filtered Results: 287
Text search:
FDA
US
Food
&
Drug
Administration
Featured
Recommendations
27
New Publications
64
Language
Document type
No document type
159
Guidelines
56
Studies & Reports
43
Manuals
12
Fact sheets
8
Strategic & Response Plan
3
Training Material
2
Resource Platforms
2
Brochures
1
Situation Updates
1
Countries / Regions
India
13
Myanmar / Burma
8
Philippines
7
Russia
7
Ghana
6
USA
6
Western and Central Europe
5
Global
4
Latin America and the Carribbean
4
Uganda
4
South Sudan
4
Thailand
3
Syria
3
Nigeria
3
Germany
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
South Africa
3
Nepal
2
Rwanda
2
Africa
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Angola
2
Tajikistan
1
Sierra Leone
1
Singapore
1
Senegal
1
Peru
1
Mozambique
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Paraguay
1
Argentina
1
Brazil
1
Namibia
1
Sudan
1
Botswana
1
Indonesia
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
53
Pharmacy & Technologies
9
Public Health
8
Women & Child Health
6
Key Resources
5
Capacity Building
3
Toolboxes
COVID-19
37
Mental Health
32
TB
30
HIV
29
AMR
22
Pharmacy
15
Ebola & Marburg
13
Specific Hazards
9
NTDs
8
NCDs
7
Rapid Response
5
Planetary Health
5
Refugee
4
Cholera
2
Conflict
2
Zika
2
Natural Hazards
1
Disability
1
Caregiver
1
Health Financing Toolbox
1
Global Health Education
1
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
10 December 2020
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Manuel d’orientation
Recommandations concernant l’utilisation de méthodes
contraceptives par les femmes exposées à un risque
élevé d’infection par le VIH
UNAIDS 2016 / Meeting Report
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m...
Document d'orientation pour le personnel de santé
El grupo de Farmacovigilancia de la red Panamericana para la Armonización Farmacéutica (PARF) de la Organización Panamericana de la Salud (OPS), ha desarrollado este documento desde la visión OPS/OMS, considerando que la farmacovigilancia es un componente esencial de los programas de salud públ...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
